NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $74.30 -2.31 (-3.02%) (As of 02:37 PM ET) Add Compare Share Share Today's Range$74.28▼$77.9450-Day Range$64.64▼$104.9652-Week Range$60.88▼$124.11Volume135,162 shsAverage Volume440,119 shsMarket Capitalization$2.32 billionP/E RatioN/ADividend YieldN/APrice Target$118.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get iRhythm Technologies alerts: Email Address iRhythm Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside58.3% Upside$118.67 Price TargetShort InterestBearish7.94% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.93Based on 6 Articles This WeekInsider TradingSelling Shares$521,081 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.66) to ($1.82) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.68 out of 5 starsMedical Sector392nd out of 927 stocksSurgical & Medical Instruments Industry48th out of 101 stocks 4.5 Analyst's Opinion Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageiRhythm Technologies has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about iRhythm Technologies' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted7.94% of the outstanding shares of iRhythm Technologies have been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 5.2.Change versus previous monthShort interest in iRhythm Technologies has recently decreased by 3.50%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRTC. Previous Next 2.2 News and Social Media Coverage News SentimentiRhythm Technologies has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for iRhythm Technologies this week, compared to 6 articles on an average week.Search InterestOnly 2 people have searched for IRTC on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $521,081.00 in company stock.Percentage Held by InsidersOnly 0.68% of the stock of iRhythm Technologies is held by insiders.Read more about iRhythm Technologies' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($2.66) to ($1.82) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -17.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -17.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 10.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about iRhythm Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Capital TrendsMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukraine was used to cyberattacks. But the WhisperGate attack just before Russia's full-scale invasion was different. It was larger... and it was aimed at dismantling Ukraine's critical infrastructure. The company's unique expertise and scalable approach allowed them to nearly double revenues between 2021-2023, and they've added another $20 million in new sales orders this year alone. There is no denying - the opportunity here is massive.Click here to learn how a small company is joining the ranks of Lockheed Martin and Raytheon About iRhythm Technologies Stock (NASDAQ:IRTC)iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Read More IRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRTC Stock News HeadlinesSeptember 11, 2024 | markets.businessinsider.comIRhythm Gets Japanese PMDA Approval For Zio ECG Monitoring SystemSeptember 11, 2024 | globenewswire.comiRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial IntelligenceSeptember 16, 2024 | Capital Trends (Ad)More Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukraine was used to cyberattacks. But the WhisperGate attack just before Russia's full-scale invasion was different. It was larger... and it was aimed at dismantling Ukraine's critical infrastructure. The company's unique expertise and scalable approach allowed them to nearly double revenues between 2021-2023, and they've added another $20 million in new sales orders this year alone. There is no denying - the opportunity here is massive.September 11, 2024 | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Consensus Recommendation of "Buy" from AnalystsSeptember 9, 2024 | markets.businessinsider.comiRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 MeetingSeptember 9, 2024 | globenewswire.comiRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 MeetingSeptember 5, 2024 | markets.businessinsider.comBuy Rating for Irhythm Technologies: Strategic Growth and Strong Regulatory ManagementSeptember 3, 2024 | markets.businessinsider.comOppenheimer Sticks to Their Buy Rating for Irhythm Technologies (IRTC)September 16, 2024 | Capital Trends (Ad)More Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukraine was used to cyberattacks. But the WhisperGate attack just before Russia's full-scale invasion was different. It was larger... and it was aimed at dismantling Ukraine's critical infrastructure. The company's unique expertise and scalable approach allowed them to nearly double revenues between 2021-2023, and they've added another $20 million in new sales orders this year alone. There is no denying - the opportunity here is massive.September 1, 2024 | globenewswire.comiRhythm Technologies Announces Results of GUARD-AF TrialAugust 29, 2024 | globenewswire.comiRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and SpainAugust 29, 2024 | globenewswire.comiRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and SpainAugust 29, 2024 | globenewswire.comiRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and SpainAugust 29, 2024 | globenewswire.comiRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and SpainAugust 21, 2024 | finance.yahoo.comiRhythm Technologies to Participate in Upcoming Investor Conferences in SeptemberAugust 18, 2024 | finance.yahoo.comIRTC Sep 2024 80.000 put (IRTC240920P00080000)August 15, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and Irhythm Technologies (IRTC)August 4, 2024 | ca.finance.yahoo.comIRTC Aug 2024 75.000 callSee More Headlines Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/01/2024Today9/16/2024Next Earnings (Estimated)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:IRTC CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,000Year FoundedN/APrice Target and Rating Average Stock Price Target$118.67 High Stock Price Target$145.00 Low Stock Price Target$100.00 Potential Upside/Downside+54.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($4.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-123,410,000.00 Net Margins-24.50% Pretax Margin-24.37% Return on Equity-84.14% Return on Assets-19.29% Debt Debt-to-Equity Ratio6.50 Current Ratio6.92 Quick Ratio6.76 Sales & Book Value Annual Sales$492.68 million Price / Sales4.86 Cash FlowN/A Price / Cash FlowN/A Book Value$6.85 per share Price / Book11.18Miscellaneous Outstanding Shares31,240,000Free Float30,893,000Market Cap$2.39 billion OptionableOptionable Beta1.22 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. Quentin S. Blackford (Age 45)President, CEO & Director Comp: $2.15MMr. Brice Bobzien CPA (Age 45)Chief Financial Officer Comp: $685.12kDr. Minang P. Turakhia M.D. (Age 50)M.S., Chief Medical & Scientific Officer and Executive VP of Product Innovation Comp: $1MMr. Patrick Michael Murphy J.D. (Age 45)Chief Business & Legal Officer Comp: $1.28MMr. Douglas J. Devine (Age 54)Executive Advisor Comp: $800kMr. Chad M. Patterson (Age 42)Chief Commercial Officer Comp: $771.51kMr. Marc Rosenbaum (Age 52)Senior VP of Finance & Chief Accounting Officer Mr. Mark J. Day Ph.D. (Age 53)Chief Technology Officer Comp: $718.76kMr. Daniel G. Wilson (Age 41)Executive VP of Corporate Development & Investor Relations Comp: $670.09kMs. Sumi Shrishrimal (Age 45)Executive VP & Chief Risk Officer More ExecutivesKey CompetitorsHaemoneticsNYSE:HAENevroNYSE:NVROPenumbraNYSE:PENGlaukosNYSE:GKOSInspire Medical SystemsNYSE:INSPView All CompetitorsInsiders & InstitutionsTruist Financial CorpSold 281 shares on 8/21/2024Ownership: 0.045%Cim Investment Management Inc.Bought 1,099 shares on 8/16/2024Ownership: 0.019%Ascent Group LLCBought 1,330 shares on 8/16/2024Ownership: 0.017%Creative PlanningBought 3,576 shares on 8/16/2024Ownership: 0.011%Algert Global LLCSold 5,149 shares on 8/16/2024Ownership: 0.010%View All Insider TransactionsView All Institutional Transactions IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $107.04 at the start of the year. Since then, IRTC stock has decreased by 30.0% and is now trading at $74.96. View the best growth stocks for 2024 here. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) announced its earnings results on Thursday, August, 1st. The company reported ($0.61) EPS for the quarter, topping analysts' consensus estimates of ($0.89) by $0.28. iRhythm Technologies's quarterly revenue was up 19.3% compared to the same quarter last year. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? Top institutional investors of iRhythm Technologies include Mackenzie Financial Corp (4.59%), Blair William & Co. IL (2.57%), Point72 Asset Management L.P. (1.72%) and Allspring Global Investments Holdings LLC (1.53%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Patrick Michael Murphy, Daniel G Wilson, Douglas Devine, Minang Turakhia, Brice Bobzien, Mervin Smith, Marc W Rosenbaum, Merz Cathleen Noel Bairey, Kevin M King and David A Vort. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD) and Advanced Micro Devices (AMD). This page (NASDAQ:IRTC) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.